It is now known that breast cancer stem cells exist in distinct mesenchymal-like (epithelial–mesenchymal transition [EMT]) as CD44+/CD24− and epithelial-like (mesenchymal-epithelial transition [MET]) states that express ALDH1. This evidence concerns the gene CD44 and breast cancer.